An open label, multicenter, phase I/II study of RP1 as a single agent and in combination with PD1 blockade in patients with solid tumors. (2019)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.2019.37.15_suppl.tps2671
Publication URI: http://dx.doi.org/10.1200/jco.2019.37.15_suppl.tps2671
Type: Journal Article/Review
Parent Publication: Journal of Clinical Oncology
Issue: 15_suppl